227 related articles for article (PubMed ID: 15105097)
1. Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
Mushtaq N; Redpath MB; Luzio JP; Taylor PW
Antimicrob Agents Chemother; 2004 May; 48(5):1503-8. PubMed ID: 15105097
[TBL] [Abstract][Full Text] [Related]
2. Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.
Zelmer A; Martin MJ; Gundogdu O; Birchenough G; Lever R; Wren BW; Luzio JP; Taylor PW
Microbiology (Reading); 2010 Jul; 156(Pt 7):2205-2215. PubMed ID: 20395269
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase.
Mushtaq N; Redpath MB; Luzio JP; Taylor PW
J Antimicrob Chemother; 2005 Jul; 56(1):160-5. PubMed ID: 15914489
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Identification by Transposon Insertion Sequencing of Escherichia coli K1 Genes Essential for
McCarthy AJ; Stabler RA; Taylor PW
J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29339415
[No Abstract] [Full Text] [Related]
5. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation.
King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER
J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779
[TBL] [Abstract][Full Text] [Related]
6.
Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
[TBL] [Abstract][Full Text] [Related]
7. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.
Kim KS; Itabashi H; Gemski P; Sadoff J; Warren RL; Cross AS
J Clin Invest; 1992 Sep; 90(3):897-905. PubMed ID: 1326000
[TBL] [Abstract][Full Text] [Related]
8. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli K1's capsule is a barrier to bacteriophage T7.
Scholl D; Adhya S; Merril C
Appl Environ Microbiol; 2005 Aug; 71(8):4872-4. PubMed ID: 16085886
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
[TBL] [Abstract][Full Text] [Related]
11. Novel Host Recognition Mechanism of the K1 Capsule-Specific Phage of
Gong Q; Wang X; Huang H; Sun Y; Qian X; Xue F; Ren J; Dai J; Tang F
J Virol; 2021 Aug; 95(18):e0092021. PubMed ID: 34191582
[TBL] [Abstract][Full Text] [Related]
12. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
[TBL] [Abstract][Full Text] [Related]
13. Cloning, expression, and purification of the K5 capsular polysaccharide lyase (KflA) from coliphage K5A: evidence for two distinct K5 lyase enzymes.
Clarke BR; Esumeh F; Roberts IS
J Bacteriol; 2000 Jul; 182(13):3761-6. PubMed ID: 10850992
[TBL] [Abstract][Full Text] [Related]
14. Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.
Wang MC; Lin WH; Tseng CC; Wu AB; Teng CH; Yan JJ; Wu JJ
Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):407-12. PubMed ID: 23052990
[TBL] [Abstract][Full Text] [Related]
15. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM
Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning of the K1 capsular polysaccharide genes of E. coli.
Silver RP; Finn CW; Vann WF; Aaronson W; Schneerson R; Kretschmer PJ; Garon CF
Nature; 1981 Feb; 289(5799):696-8. PubMed ID: 7007894
[TBL] [Abstract][Full Text] [Related]
17. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
Bortolussi R; Ferrieri P; Björkstén B; Quie PG
Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of genes encoding virulence factors among Escherichia coli with K1 antigen and non-K1 E. coli strains.
Kaczmarek A; Budzyńska A; Gospodarek E
J Med Microbiol; 2012 Oct; 61(Pt 10):1360-1365. PubMed ID: 22745135
[TBL] [Abstract][Full Text] [Related]
19. Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli.
Pelkonen S; Aalto J; Finne J
J Bacteriol; 1992 Dec; 174(23):7757-61. PubMed ID: 1447142
[TBL] [Abstract][Full Text] [Related]
20. ColV increases the virulence of Escherichia coli K1 strains in animal models of neonatal meningitis and urinary infection.
Aguero ME; de la Fuente G; Vivaldi E; Cabello F
Med Microbiol Immunol; 1989; 178(4):211-6. PubMed ID: 2664439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
